The findings reveal the distribution of ices in ... Dec. 12, 2024 — Stars similar to the Sun produce a gigantic outburst of radiation on average about once every hundred years per star.

Adding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration-resistant prostate ...

Evan Y. Yu, MD, discusses the safety data from the phase 3 PEACE-3 study of enzalutamide (ENZA) combined with radium-223 (Ra-223) for androgen receptor pathway inhibitor (ARPI)–naive metastatic ...

Evan Y. Yu, MD, discusses the key efficacy findings from the PEACE-3 study, which assessed the combination of enzalutamide (ENZA) and radium-223 (Ra-223) in androgen receptor pathway inhibitor ...

Journal of Nuclear Medicine February 2025, jnumed.124.268340; DOI: https://doi.org/10.2967/jnumed.124.268340 ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.77% to 1,753.40 Indian rupees Wednesday, on what proved to be an all-around poor trading session for the stock market, with the BSE ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Polymorphic light eruption (PMLE), commonly known as a sun rash or sun poisoning, is a type of photodermatosis triggered by an immune system reaction to the sun's ultraviolet (UV) radiation. Not ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

The incorporation of AI and digital pathology is now being shown to help better select patients with nmCRPC who might most benefit from treatment intensification. The Artera MMAI tool produced scores ...

Sun Pharma announced a 15 per cent year-on-year (YoY) increase, reaching ₹2,903 crore for the quarter ending December 2024. The company also recorded an exceptional item of ₹316 crore during ...